Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6189366 | Brachytherapy | 2013 | 8 Pages |
Abstract
Preoperative HDRB for high-risk ESCCs represents a well-tolerated procedure, which leads to a high rate of postoperative pathologic response. Dose-volume histogram parameters were at least equivalent to those obtained with a low-dose-rate procedure. Long-term results will help to analyze the place of preoperative brachytherapy in the management of high-risk ESCCs.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Jean-Michel Hannoun-Levi, Marie-Eve Chand-Fouche, Mathieu Gautier, Catherine Dejean, Myriam Marcy, Yves Fouche,